Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy
Not Applicable
Completed
- Conditions
- Corneal Disease
- Interventions
- Procedure: ALK (automated lamellar keratectomy)Drug: Mitomycin
- Registration Number
- NCT00654888
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
To relieve pain in patients with symptomatic bullous keratopathy (BK) until keratoplasty and in patients without visual prediction.
The automated lamellar keratectomy represents a alternative in treatment of pain in symptomatic patients with BK.
- Detailed Description
Only patients with BK symptomatic (with pain) were submitted to automated lamellar keratectomy (ALK).
Complete ophthalmological examination including UCVA,BSVA, biomicroscopy, tonometry, esthesiometry, UBM pachymetry, impression cytology and pain questionnaire were performed in preoperative, postoperative of one, seven, 30, 90, 180 days and one year.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- Patient with bullous keratopathy symptomatic (with pain)
Read More
Exclusion Criteria
- herpetic endotelial disorders
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 ALK (automated lamellar keratectomy) automated lamellar keratectomy without mitomycin 1 Mitomycin Group one submitted to automated lamellar keratectomy(ALK) with mitomycin (0,02% in 30 seconds after keratectomy).
- Primary Outcome Measures
Name Time Method Pain questionnaire preoperative and postoperative 1,7,30,90,180 days and one year
- Secondary Outcome Measures
Name Time Method biomicroscopy, esthesiometry, UBM pachymetry, impression cytology preoperative, postoperative 1,7,30,90,180 days and one year